Optimi Health (OPTHF) Stock Price, Quote, News & History

Optimi Health Corp (OPTHF) Stock Price, Quote, News & History

OPTHFOTCQX

Trade with Public

$0.2064

0.00241.18%

Last update: Mar 26, 2:18 PM

Key Statistics

Open

$0.20

Volume / Avg.

10.40K / 34.69K

Day Range

$0.20 - $0.21

52 Wk Range

0.10 - 0.29

Market Cap

$19.97M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Optimi Health Corp News

Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition

Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships.

Juan Spínelli

New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia

Canada Magic Mushrooms and MDMA market is hitting new milestones as canada has licensed Optimi to export psilocybin and MDMA to Australia

Rolando García

Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute

Lara Goldstein

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-2.96M

Investing Cash Flow (TTM)

-70.13K

Financing Cash Flow (TTM)

3.44M

Free Cash Flow (TTM)

-3.03M

Capital Expenditure (TTM)

-70.13K

Net Change in Cash (TTM)

409.25K

Valuation Metrics

Enterprise Value

$24.45M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

138.89

PB Ratio (TTM)

5.40

Earnings Yield % (TTM)

-17.81%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.04

Company Debt

Total Debt

$6.37M

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$49.58K

Total Cash

$491.75K

Debt to Equity

1.30

Issuance of Debt (TTM)

-$49.58K

Repayment of Debt (TTM)

-$49.58K

Key Statistics

Open

$0.20

Volume / Avg.

10.40K / 34.69K

Day Range

$0.20 - $0.21

52 Wk Range

0.10 - 0.29

Market Cap

$19.97M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribut...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Optimi Health (OPTHF) stock?

You can purchase shares of Optimi Health (OTCQX:OPTHF) through any online brokerage.

View our list of the best stock brokerages

Who are Optimi Health (OPTHF) competitors?

There are no as such competitors for Optimi Health.

What is the forecast, or price target, for Optimi Health (OPTHF) stock?

There is no analysis for Optimi Health to provide a consensus price target.

What is the current price for Optimi Health (OPTHF)?

The stock price for Optimi Health (OTCQX: OPTHF) is $0.2064 last updated March 26, 2026 at 2:18 PM EDT.

Does Optimi Health (OPTHF) pay a dividend?

There are no upcoming dividends for Optimi Health.

When is Optimi Health (OTCQX:OPTHF) reporting earnings?

Optimi Health does not have any upcoming earnings scheduled.

Is Optimi Health (OPTHF) going to split?

There is no upcoming split for Optimi Health.

What sector and industry does Optimi Health (OPTHF) operate in?

Optimi Health is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQX.

Key Statistics

Open

$0.20

Volume / Avg.

10.40K / 34.69K

Day Range

$0.20 - $0.21

52 Wk Range

0.10 - 0.29

Market Cap

$19.97M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Optimi Health Corp News

Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition

Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships.

Juan Spínelli

New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia

Canada Magic Mushrooms and MDMA market is hitting new milestones as canada has licensed Optimi to export psilocybin and MDMA to Australia

Rolando García

Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute

Lara Goldstein